Dementia

Definition

  • Loss of intellectual abilities previously attained (memory, judgment, abstract thought, and other higher cortical functions) severe enough to interfere with social and/or occupational functioning.

Clinical features

  • Memory deficit
    • Cardinal feature;
  • DSM-IV definition requires impairment in at least one other domain (language, perception, visuospatial function, calculation, judgment, abstraction, problem-solving skills).

Numbers

  • Affects 3–11% of community-dwelling adults > 65 yrs of age,
    • Greater presence among institutionalized residents.

Risk factors

  • Advanced age
  • Family history of dementia
  • Apolipoprotein E-4 allele

Brain biopsy for dementia.

  • Rarely needed
    • Clinical criteria are usually sufficient for the diagnosis of most dementias.
  • Biopsy indication
    • Chronic progressive cerebral disorder with an unusual clinical course where all other possible diagnostic methods have been exhausted and have failed to provide adequate diagnostic certainty.
    • Eg
  • Biopsy may show
    • CJD
      • The high incidence of CJD among patients selected for biopsy under these criteria necessitates appropriate precautions;
    • Low grade astrocytoma
    • AD
  • Specimen
    • Be large enough (usually 1cm³)
    • Be taken from an affected area
    • Include gray and white matter, pia and dura
    • Be handled carefully to minimize artifact (electrocautery should not be used on the specimen side of the incision)
  • Diagnostic yield
    • 20% (6% were only suggestive of a diagnosis, 66% were abnormal but nonspecific, 8% were normal).
    • The yield was highest in those with focal MRI abnormalities.
      • Perform MRI and if not abnormalities use SPECT or PET scan
    • Out of 10 pt with biopsies, the biopsy result led to a meaningful therapeutic intervention in only 4.

Differential diagnosis

  • Delirium
    • AKA acute confusional state.
    • Distinct from dementia;
      • Patients with dementia are at increased risk of developing delirium.
    • A primary disorder of attention that subsequently affects all other aspects of cognition.
    • Often represents life-threatening illness
      • e.g. hypoxia, sepsis, uremic encephalopathy, electrolyte abnormality, drug intoxication, MI.
    • 50% of patients die within 2 yrs of this diagnosis.
    • Delirium vs. dementia (critical distinction)
      • Unlike dementia, delirium has acute onset, motor signs (tremor, myoclonus, asterixis), slurred speech, altered consciousness (hyperalert/agitated or lethargic, or fluctuations), hallucinations may be florid.
      • EEG shows pronounced diffuse slowing.

Summary

Disease
Presentation
Diagnostics
Other
Treatment
Wernicke’s encephalopathy
- Acute dementia
- Horizontal gaze palsy
- Ataxia
MRI FLAIR: signal increased in
- Mammillary bodies
- Dorsomedial thalamus
- Tectal plate
- Periaqueductal area near 3rd ventricle
Deficiency of thiamine (vitamin B1):
- Chronic alcoholism
- Malnutrition
- Chemotherapy
100-mg thiamine (B1) IV + daily oral administration
Korsakoff’s syndrome
- Chronic dementia
- Amnesia
- Confabulation
Deficiency of thiamine (vitamin B1):
- Chronic alcoholism
- Malnutrition
- Chemotherapy
100-mg thiamine (B1) IV + daily oral administration
- Dementia
- Myoclonus
- Ataxia, clumsiness, dysarthria, diplopia, vision changes, cortical blindness
- Visual agnosia, color perception changes
1. EEG: periodic spikes at 1–2 Hz frequency (PSWC)
2. Lumbar puncture: normal/increased protein; 14–3–3 protein has highest sensitivity and specificity for CJD
3. MRI (FLAIR and DWI): abnormalities in cerebral cortex/striatum/thalamus
Treatment: NONE
Prognosis: death in <1 year
Most common cause of dementia
MRI: temporal and parietal atrophy
Neurofibrillary tangle (abnormally phosphorylated tau protein; may also be present in other disease) + senile plaques (β-amyloid)
1. Cholinesterase inhibitors/memantine (for cognitive symptoms)
2. Selective serotonin reuptake inhibitors (for depression)
3. Atypical antipsychotics (for agitation). Use of this medication may increase risk of mortality, cerebrovascular events, cardiovascular and metabolic complications, infections, falls.
4. Do not use benzodiazepines
Prognosis: death in 5 years: 70%
- Dementia
- Changes in behavior
- Progressive nonfluent aphasia
MRI: frontal + temporal atrophy
Tau proteins in neurons (silver staining: Pick’s bodies)
There is no therapy
- Second most common cause of dementia
- Sleep disturbance
- May include Parkinsonian symptoms
MRI: temporal + parietal + occipital atrophy
Lewy bodies: alpha-synuclein protein in neurons
1. Cholinesterase inhibitors (for cognitive symptoms)
2. Levodopa (in case of significant Parkinsonian symptoms)
3. Melatonin/clonazepam (for sleep disorders)
4. Use atypical antipsychotics if absolutely necessary, avoid the typical ones
Transient global amnesia (TGA)
- Complete, reversible anterograde and retrograde memory loss (≤24h)
- Persistent memory loss during attack (bewilderment, repeating questions)
- Retained identity and complex task performance
- Middle/older aged men
- Emotional/other stressors (physical/sexual exertion)
- Not associated with increased stroke risk
Clinical diagnosis
Supportive
Huntington’s Disease
- Dementia
- Delusions
- Dysarthria
- Tremor
- Myoclonus
- Seizures
- Spasticity
- Argyll Robertson pupils
Clinical diagnosis
Supportive
Neurosyphilis (general paresis)
- Dementia, delusions, dysarthria, tremor, myoclonus, seizures, spasticity, Argyll Robertson pupils
- Chronic, insidious meningoencephalitis
- May delay ≤20years after initial infection
- Other: meningitis, meningovascular syphilis, optic atrophy, tabes dorsalis (ataxia, urinary incontinence, lightning pains)
Serology (Syphilis), CSF, clinical assessment
May develop years after syphilitic infection
Treat underlying infection
Hypothyroidism in adults
- Headache
- Dementia
- Psychosis
- Decreased consciousness
- Macroglossia (due to mucopolysaccharides)
- Proximal myopathic weakness
- Delayed relaxation phase of reflexes
Thyroid function tests
Thyroid hormone replacement